Leveraging the U.S. Criminal Justice System to Access Women for HIV Interventions
The criminal justice (CJ) system can be leveraged to access women for HIV prevention and treatment programs. Research is lacking on effective implementation strategies tailored to the specific needs of CJ-involved women. We conducted a scoping review of published studies in English from the United States that described HIV interventions, involved women or girls, and used the CJ system as an access point for sampling or intervention delivery. We identified 350 studies and synthesized data from 42 unique interventions, based in closed (n = 26), community (n = 7), or multiple/other CJ settings (n = 9). A minority of reviewed programs incorporated women-specific content or conducted gender-stratified analyses. CJ systems are comprised of diverse access points, each with unique strengths and challenges for implementing HIV treatment and prevention programs for women. Further study is warranted to develop women-specific and trauma-informed content and evaluate program effectiveness.
KeywordsHIV Intervention Criminal justice Women Systematic review Implementation science
Research support provided by the National Institutes on Drug Abuse (K23 DA033858 to JPM; K24 DA017072 to FLA), and National Institute of Allergy and Infectious Diseases (T32 AI007517 to DM). Funding sources played no role in data collection, analysis, drafting of the manuscript, or decision to submit the manuscript for publication.
Compliance with Ethical Standards
Conflict of interest
All authors declare no conflict of interest.
This article does not contain any studies with human participants performed by any of the authors.
- 4.Maruschak L. Bureau of justice statistics bulletin: HIV in prisons, 2007–2008. 2009. http://bjs.ojp.usdoj.gov/index.cfm?ty=pbdetail&iid=1747.
- 5.International Centre for Prison Studies. World Prison Brief. 2014. http://www.prisonstudies.org/country/united-states-america.
- 9.Meyer J, Altice F. HIV in injection and other drug users. Sexually transmitted infections. 2nd ed. Amsterdam: Elsevier Publications; 2011.Google Scholar
- 11.Maruschak LM, Beaver R. HIV in Prisons, 2008. Washington, D.C.: U.S. Department of Justice, Office of Justice Programs BoJS; 2009 December 2009. Report No.: NCJ 228307 Contract No.: NCJ 228307.Google Scholar
- 14.World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment, and care for key populations. Geneva: Switzerland; 2014.Google Scholar
- 15.The White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States: updated to 2020. Washington, D.C. 2015.Google Scholar
- 16.Centers for Disease Control and Prevention. Effective Interventions: HIV Prevention that Works. 2015. https://effectiveinterventions.cdc.gov/en.
- 18.Estelle v. Gamble. Sect. 429 (1976).Google Scholar
- 26.Flanigan T, Zaller N, Beckwith CG, Bazerman LB, Rana A, Gardner A, et al. Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S78–83.CrossRefPubMedGoogle Scholar
- 32.Bureau of Justice Statistics. The justice system. 2016. http://www.bjs.gov/content/justsys.cfm#structure.
- 34.Saber-Tehrani AS, Springer SA, Qiu J, Herme M, Wickersham J, Altice FL. Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community—a potential conduit to improved HIV treatment outcomes. Contemp Clin Trials. 2011;33:436–44.CrossRefPubMedGoogle Scholar
- 35.White BL, Golin CE, Grodensky CA, Kiziah CN, Richardson A, Hudgens MG, et al. Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study. AIDS Behav. 2015;19(1):128–36.CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Knudsen HK, Staton-Tindall M, Oser CB, Havens JR, Leukefeld CG. Reducing risky relationships: a multisite randomized trial of a prison-based intervention for reducing HIV sexual risk behaviors among women with a history of drug use. AIDS Care. 2014;26(9):1071–9.CrossRefPubMedPubMedCentralGoogle Scholar
- 45.Rhodes W, Gross M. Case management reduces drug use and criminality among drug-involved arrestees: an experimental study of an HIV prevention intervention. Rockville, MD: National Institute of Justice and the National Institute on Drug Abuse; 1997.Google Scholar
- 50.Weir BW, O’Brien K, Bard RS, Casciato CJ, Maher JE, Dent CW, et al. Reducing HIV and partner violence risk among women with criminal justice system involvement: a randomized controlled trial of two motivational interviewing-based interventions. AIDS Behav. 2009;13(3):509–22.CrossRefPubMedGoogle Scholar
- 54.Centers for Disease Control. HIV among women. 2016. http://www.cdc.gov/hiv/group/gender/women/.
- 55.World Health Organization. Global health observatory data: number of women living with HIV. 2016. http://www.who.int/gho/hiv/epidemic_status/cases_adults_women_children_text/en/.
- 62.World Health Organization. Tool to set and monitor targets for HIV preventions, diagnosis, treatment, and care for key populations: supplement to the 2014 consolidated guidelines for HIV prevention, diagnosis, treatment, and care for key populations Geneva, Switzerland: 2015.Google Scholar
- 64.Loeliger KB, Biggs ML, Young R, Kahana SY, Seal DW, Beckwith CG, et al. Gender differences in HIV risk behaviors among persons involved in the U.S. criminal justice system and living with HIV or at risk for HIV: a “seek, test, treat, and retain” harmonization consortium. AIDS Behav. 2017; In press.Google Scholar
- 66.DiClemente RJ, Davis TL, Swartzendruber A, Fasula AM, Boyce L, Gelaude D, et al. Efficacy of an HIV/STI sexual risk-reduction intervention for African American adolescent girls in juvenile detention centers: a randomized controlled trial. Women Health. 2014;54(8):726–49.CrossRefPubMedPubMedCentralGoogle Scholar
- 80.St. Lawrence JS, Eldridge GD, Shelby MC, Little CE, Brasfield TL, O’Bannon IRE. HIV risk reduction for incarcerated women: A comparison of brief interventions based on two theoretical models. Journal of Consulting and Clinical Psychology. 1997;65(3):504–9.Google Scholar
- 82.Di Paola A, Lincoln T, Skiest DJ, Desabrais M, Altice FL, Springer SA. Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community. Contemp Clin Trials. 2014;39(2):256–68.CrossRefPubMedPubMedCentralGoogle Scholar
- 88.Saber-Tehrani AS, Springer SA, Qiu J, Herme M, Wickersham J, Altice FL. Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - A potential conduit to improved HIV treatment outcomes. Contemp Clin Trials. 2011.Google Scholar
- 89.Altice F, Saber-Tehrani A, Qiu J, Herme M. Abstract #543: DAART is superior to self-administered therapy among released HIV+ prisoners: results from a randomized controlled trial. Boston: CROI; 2011.Google Scholar
- 90.Wohl DA, Scheyett A, Golin CE, White B, Matuszewski J, Bowling M, et al. Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial. AIDS Behav. 2011;15(2):356–64.CrossRefPubMedPubMedCentralGoogle Scholar
- 99.Rhodes W, Gross M. Case Management Reduces Drug Use and Criminality Among Drug-Involved Arrestees: An Experimental Study of an HIV Prevention Intervention. Rockville, MD: 1997.Google Scholar